Revenue | ₹11.59Cr |
Net Profits | ₹3.16Cr |
Net Profit Margins | 27.26% |
Shukra Pharmaceuticals Ltd’s revenue fell -40.41% since last year same period to ₹11.59Cr in the Q3 2024-2025. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 76.41% jump in its revenue since last 3-months.
Shukra Pharmaceuticals Ltd’s net profit fell -66.45% since last year same period to ₹3.16Cr in the Q3 2024-2025. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 485.19% jump in its net profits since last 3-months.
Shukra Pharmaceuticals Ltd’s net profit margin fell -43.7% since last year same period to 27.26% in the Q3 2024-2025. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 231.72% jump in its net profit margins since last 3-months.
The revenue for Shukra Pharmaceuticals Ltd in the Q3 results 2024 was ₹11.59Cr.
The net profit for Shukra Pharmaceuticals Ltd in the Q3 results 2024 was ₹3.16Cr.
The net profit margin for Shukra Pharmaceuticals Ltd in the Q3 results 2024 was 27.26%.
The revenue for Shukra Pharmaceuticals Ltd in the Q3 results 2023 was ₹19.45Cr.
The net profit for Shukra Pharmaceuticals Ltd in the Q3 results 2023 was ₹9.42Cr.
The net profit margin for Shukra Pharmaceuticals Ltd in the Q3 results 2023 was 48.43%.